Stay updated with breaking news from Thersys aktie. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
16.08.2023 - Athersys, Inc. (Nasdaq: ATHX), a regenerative medicine company developing MultiStem (invimestrocel) cell therapy for critical care indications, announced financial results for the three and six months ended June 30, 2023 and provided a business . ....